{"id":2260,"date":"2022-07-22T14:32:18","date_gmt":"2022-07-22T13:32:18","guid":{"rendered":"https:\/\/www.fytofontana.com\/?p=2260"},"modified":"2022-08-30T15:29:28","modified_gmt":"2022-08-30T14:29:28","slug":"vyvoj-terapeutickej-masky","status":"publish","type":"post","link":"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/","title":{"rendered":"V\u00fdzva na predkladanie pon\u00fak"},"content":{"rendered":"\n<p class=\"has-text-align-center\">z\u00e1kazka zad\u00e1van\u00e1 osobou, ktorej poskytne SO viac ako 50 %&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-center\">alebo 50 % a menej finan\u010dn\u00fdch prostriedkov z&nbsp;NFP&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-center\">(\u010falej len \u201ezad\u00e1vate\u013e\u201c)&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-center\">Herb-Pharma Corporation s.r.o.; Ve\u013ek\u00e9 Ludince 654; 935 65 Ve\u013ek\u00e9 Ludince<\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong>V\u00fdzva na predkladanie pon\u00fak<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center\">v&nbsp;r\u00e1mci realiz\u00e1cie procesu zad\u00e1vania z\u00e1kazky pod\u013ea aktu\u00e1lne platnej Jednotnej pr\u00edru\u010dky pre \u017eiadate\u013eov\/prij\u00edmate\u013eov k&nbsp;procesu a kontrole verejn\u00e9ho obstar\u00e1vania\/obstar\u00e1vanie, verzia 2, vydan\u00e1 a \u00fa\u010dinn\u00e1 od 31.03.2022 Ministerstvom invest\u00edci\u00ed, region\u00e1lneho rozvoja a informatiz\u00e1cie Slovenskej republiky , ktor\u00e9 je centr\u00e1lnym koordina\u010dn\u00fdm org\u00e1nom.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong>\u201eV\u00fdvoj terapeutickej masky\u201c<\/strong><\/p>\n\n\n\n<ol><li>1, <strong>Identifik\u00e1cia zad\u00e1vate\u013ea:&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<p>N\u00e1zov zad\u00e1vate\u013ea:<strong> Herb-Pharma Corporation s.r.o.<\/strong><\/p>\n\n\n\n<p>S\u00eddlo: Ve\u013ek\u00e9 Ludince 654, 935 65 Ve\u013ek\u00e9 Ludince<\/p>\n\n\n\n<p>I\u010cO: 36565016<\/p>\n\n\n\n<p>DI\u010c: 2021888396<\/p>\n\n\n\n<p>I\u010c DPH: SK2021888396<\/p>\n\n\n\n<p>\u0160tatut\u00e1rny z\u00e1stupca: Ing. Ondrej Michlo &#8211; konate\u013e<\/p>\n\n\n\n<p>Mana\u017e\u00e9r VO: Ing. Silvia Berekov\u00e1<\/p>\n\n\n\n<p>Kontaktn\u00e1 osoba: Mgr. Marko Stanko \u2013 administrator VO &nbsp;<\/p>\n\n\n\n<p>Tel.: +421&nbsp;&nbsp;917&nbsp;365 692<\/p>\n\n\n\n<p>E-mail: <a href=\"mailto:marko.stanko@eufc.sk\">marko.stanko@eufc.sk<\/a> &nbsp;<\/p>\n\n\n\n<ol start=\"2\"><li>2, <strong>Miesto predlo\u017eenia\/doru\u010denia ponuky:&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<p><em>Herb-Pharma Corporation s.r.o, Ve\u013ek\u00e9 Ludince 654, 935 65 Ve\u013ek\u00e9 Ludince<\/em><\/p>\n\n\n\n<p>3. <strong>Kontaktn\u00e1 osoba na prevzatie ponuky elektronicky:&nbsp;<\/strong><\/p>\n\n\n\n<p>Mgr. Marko Stanko <a href=\"mailto:marko.stanko@eufc.sk\">marko.stanko@eufc.sk<\/a>&nbsp;<\/p>\n\n\n\n<p>4. <strong>Predmet obstar\u00e1vania: V\u00fdvoj terapeutickej masky<\/strong><\/p>\n\n\n\n<p><em>Spolo\u010dn\u00fd slovn\u00edk obstar\u00e1vania (CPV):&nbsp;<\/em><\/p>\n\n\n\n<p>73100000-3 \u2013 V\u00fdskum a v\u00fdvoj a s\u00favisiace poradensk\u00e9 slu\u017eby&nbsp;<\/p>\n\n\n\n<p>5. <strong>Typ zmluvy, ktor\u00e1 bude v\u00fdsledkom obstar\u00e1vania:&nbsp;<\/strong><\/p>\n\n\n\n<p>S&nbsp;\u00faspe\u0161n\u00fdm uch\u00e1dza\u010dom&nbsp; bude uzatvoren\u00e1 Zmluva o dielo v&nbsp;s\u00falade s \u00a7 536 a nasl. z\u00e1kona \u010d. 513\/1991 Zb. Obchodn\u00fd z\u00e1konn\u00edk v znen\u00ed neskor\u0161\u00edch predpisov medzi zmluvn\u00fdmi stranami.&nbsp;<\/p>\n\n\n\n<p>Zmluva nadobudne platnos\u0165 d\u0148om jej podpisu oboma zmluvn\u00fdmi stranami a \u00fa\u010dinnos\u0165 po splnen\u00ed odkladacej podmienky, ktor\u00e1 spo\u010d\u00edva v tom, \u017ee d\u00f4jde k:<\/p>\n\n\n\n<p>a) schv\u00e1leniu postupov v r\u00e1mci administrat\u00edvnej kontroly obstar\u00e1vania&nbsp; na z\u00e1klade schv\u00e1lenej \u017eiadosti Objedn\u00e1vate\u013ea&nbsp; o poskytnutie nen\u00e1vratn\u00e9ho finan\u010dn\u00e9ho pr\u00edspevku, alebo<\/p>\n\n\n\n<p>b) odoslaniu jednostrann\u00e9ho p\u00edsomn\u00e9ho ozn\u00e1menia o&nbsp;nadobudnut\u00ed \u00fa\u010dinnosti zmluvy Objedn\u00e1vate\u013ea Zhotovite\u013eovi.<\/p>\n\n\n\n<p>Objedn\u00e1vate\u013e si vyhradzuje pr\u00e1vo bez ak\u00fdchko\u013evek sankci\u00ed odst\u00fapi\u0165 od zmluvy so Zhotovite\u013eom v pr\u00edpade, kedy v\u00fdsledky administrat\u00edvnej finan\u010dnej kontroly poskytovate\u013ea nen\u00e1vratn\u00e9ho finan\u010dn\u00e9ho pr\u00edspevku v&nbsp;s\u00falade so zmluvou o&nbsp;poskytnut\u00ed NFP neumo\u017e\u0148uj\u00fa financovanie v\u00fddavkov vzniknut\u00fdch z obstar\u00e1vania tovarov, slu\u017eieb, stavebn\u00fdch pr\u00e1c alebo in\u00fdch postupov.<\/p>\n\n\n\n<p>Po\u017eiadavky zad\u00e1vate\u013ea uveden\u00e9 v n\u00e1vrhu Zmluvy o dielo s\u00fa pre uch\u00e1dza\u010da z\u00e1v\u00e4zn\u00e9.<\/p>\n\n\n\n<p><strong><em>N\u00e1vrh Zmluvy o dielo<\/em><\/strong> tvor\u00ed <strong><em>Pr\u00edlohu \u010d. 4<\/em><\/strong> tejto v\u00fdzvy.<\/p>\n\n\n\n<ol start=\"6\"><li>6, <strong>Podrobn\u00fd opis predmetu z\u00e1kazky (predmetu obstar\u00e1vania):<\/strong> predmetom z\u00e1kazky je V\u00fdvoj terapeutickej masky, ktor\u00e1m\u00e1 pozost\u00e1va\u0165 z&nbsp;nasledovn\u00fdch technologick\u00fdch komponentov:<strong>&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<ol><li>1, <strong>Nosn\u00e1 jednotka pripojite\u013en\u00e1 k tv\u00e1ri<\/strong>&nbsp;<\/li><\/ol>\n\n\n\n<ul><li>materi\u00e1l z nedr\u00e1\u017ediv\u00e9ho materi\u00e1lu pre \u013eudsk\u00fa poko\u017eku,<\/li><li>dobre fixovan\u00e1,&nbsp;<\/li><li>jednoduch\u00e1 in\u0161tal\u00e1cia.&nbsp;<\/li><li>povrch obohaten\u00fd o \u0161peci\u00e1lny povlak z oxidu titani\u010dit\u00e9ho.&nbsp;<\/li><\/ul>\n\n\n\n<p><strong>Parametre sk\u00faman\u00e9 po\u010das v\u00fdvoja:<\/strong>&nbsp;<\/p>\n\n\n\n<p>a) <strong>Modelovanie straty aeros\u00f3lu<\/strong> \u2013 z&nbsp;r\u00f4znych v\u00fdrobn\u00fdch materi\u00e1lov sa meria mno\u017estvo \u00fa\u010dinnej l\u00e1tky viazanej povrchom. Po evapor\u00e1cii l\u00e1tok r\u00f4znych mno\u017estiev sa porovn\u00e1va pomer medzi vyl\u00fa\u010denou l\u00e1tkou a&nbsp;l\u00e1tkou absorbovanou na povrchu. Ur\u010denie miery adsorpcie peptidov. K&nbsp;meraniu sa pou\u017eije adsorpcia peptidov 280\/260 nm.&nbsp;<\/p>\n\n\n\n<p>b) <strong>Odolnos\u0165 proti hub\u00e1m a&nbsp;bakt\u00e9ri\u00e1m<\/strong> sa bude sk\u00fa\u0161a\u0165 mikrobiologick\u00fdmi met\u00f3dami z&nbsp;r\u00f4znych v\u00fdrobn\u00fdch materi\u00e1lov. Pre testovanie sa kolekcia kme\u0148ov bakt\u00e9ri\u00ed a&nbsp;h\u00fab vyber\u00e1 na z\u00e1klade medzin\u00e1rodn\u00fdch predpisov.&nbsp;<\/p>\n\n\n\n<p>c) <strong>Testovanie rezistencie proti dezinfek\u010dn\u00fdm prostriedkom<\/strong>. Vyberie sa kolekcia dezinfek\u010dn\u00fdch prostriedkov troch skup\u00edn \u00fa\u010dinn\u00fdch l\u00e1tok. Testovanie sa realizuje aj bez bakt\u00e9ri\u00ed, a&nbsp;tie\u017e pri danom po\u010dte bakt\u00e9ri\u00ed. \u00da\u010dinnos\u0165 dezinfek\u010dn\u00e9ho prostriedku sa nastav\u00ed poklesom 6 log.&nbsp;<\/p>\n\n\n\n<p>d) <strong>Odolnos\u0165 vo\u010di UV \u017eiareniu.<\/strong> Varianty r\u00f4znych v\u00fdrobn\u00fdch materi\u00e1lov sa vystavia \u017eiareniu UV-A(400\u2013315nm) a UV-B(315\u2013280 nm) pri zoh\u013eadnen\u00ed parametrov ur\u010den\u00fdch v\u00fdrobcom \u0161peci\u00e1lneho povlaku z oxidu titani\u010dit\u00e9ho.&nbsp;<\/p>\n\n\n\n<ol start=\"2\"><li>2, <strong>Evapor\u00e1tor<\/strong>&nbsp;<\/li><\/ol>\n\n\n\n<ul><li>tekut\u00e1 zmes 5 ml lie\u010div\u00fdch rastl\u00edn a&nbsp;peptidov sa evoporuje do 10 min.,<\/li><li>teplota evapor\u00e1cie nepresahuje 45 \u00b0C,&nbsp;<\/li><li>\u00farove\u0148 naplnenosti \u00fa\u010dinnej l\u00e1tky kontroluje \u0161peci\u00e1lny senzor,&nbsp;<\/li><li>napr\u00e1zdno sa ned\u00e1 na\u0161tartova\u0165,<\/li><li>\u013eahko sa \u010distite\u013en\u00fd,&nbsp;<\/li><li>vyroben\u00e9 z&nbsp;biodegrad\u00e1biln\u00e9ho materi\u00e1lu,<\/li><li>skoro nehlu\u010dn\u00fd,<\/li><li>nap\u00e1janie&nbsp;baterkou,&nbsp;<\/li><li>prenosn\u00e9 vyhotovenie.&nbsp;<\/li><li>sterilizovate\u013en\u00fd UV svetlom.&nbsp;<\/li><\/ul>\n\n\n\n<p><strong>Parametre sledovan\u00e9 po\u010das v\u00fdvoja:<\/strong>&nbsp;<\/p>\n\n\n\n<p>a) <strong>Sk\u00famanie diagramu pora\u010dnej r\u00fdchlosti<\/strong> pr\u00edpravkov r\u00f4znych mno\u017estiev a&nbsp;zlo\u017een\u00ed (extraktov z&nbsp;lie\u010div\u00fdch rastl\u00edn + peptidy) v&nbsp;z\u00e1vislosti od viskozity. Anal\u00fdza a&nbsp;kontrola \u00fa\u010dinnosti pr\u00edpadn\u00e9ho zostatkov\u00e9ho materi\u00e1lu.&nbsp;<\/p>\n\n\n\n<p>b) <strong>Sk\u00famanie pora\u010dnej r\u00fdchlosti a&nbsp;UH frekvencie.<\/strong> Optimaliz\u00e1cia r\u00fdchlosti v\u00fdberom najvy\u0161\u0161ieho UH pri udr\u017ean\u00ed termometrick\u00fdch parametrov pod 45 \u00b0C.&nbsp;<\/p>\n\n\n\n<p>c) <strong>Viskozita<\/strong> \u2013 optimaliz\u00e1cia profilu pora\u010dn\u00e9ho volumenu.&nbsp;<\/p>\n\n\n\n<p>d) <strong>Sk\u00famanie profilu pora\u010dn\u00fdch \u010dast\u00edc.<\/strong> Maximaliz\u00e1cia nastavenia profilu najefekt\u00edvnej\u0161\u00edch 3 \u00b5m-ov\u00fdch \u010dast\u00edc. Pre sk\u00fa\u0161anie sa pou\u017eije \u0161peci\u00e1lna met\u00f3da merania, tzv. meranie dynamick\u00e9ho rozptylu svetla (Dynamic Light Scattering, DLS). Prebieha tu sk\u00famanie zmien rozpt\u00fdlen\u00e9ho svetla v&nbsp;\u010dase, vytv\u00e1ranie a&nbsp;anal\u00fdza \u0161peci\u00e1lnych korela\u010dn\u00fdch funkci\u00ed. Po\u010das stanovenia \u00fa\u010dasti \u010dast\u00edc r\u00f4znej ve\u013ekosti sa v&nbsp;prvom rade odhadne \u00fa\u010das\u0165 \u010dast\u00edc r\u00f4znej ve\u013ekosti pod\u013ea intenzity sign\u00e1lu.&nbsp;<\/p>\n\n\n\n<p>e) <strong>Sk\u00famanie teplotn\u00e9ho profilu.<\/strong> Po z\u00edskan\u00ed teplotn\u00e9ho profilu stability akt\u00edvnych ingredienci\u00ed vytvoren\u00fdch s&nbsp;r\u00f4znym obsahom \u00fa\u010dinn\u00fdch l\u00e1tok sa porovn\u00e1vaj\u00fa profily s&nbsp;r\u00f4znou dobou evapora\u010dnej tepelnej z\u00e1\u0165a\u017ee. Z\u00e1kladom porovn\u00e1vania materi\u00e1lov je in vitro testovanie \u00fa\u010dinnosti. V\u00fdvojom terapeutickej masky m\u00e1 \u017eiadate\u013e za cie\u013e n\u00e1js\u0165 rie\u0161enie s&nbsp;dezinfikovan\u00edm masky, nako\u013eko sa maska ned\u00e1 dezinfikova\u0165 vysok\u00fdm teplom ani agres\u00edvnymi \u010dinidlami z&nbsp;h\u013eadiska citlivosti elektroniky.&nbsp;<\/p>\n\n\n\n<p><strong>V\u00fdsledkom v\u00fdvoja bude terapeutick\u00e1 maska ktor\u00e1&nbsp; bude sp\u013a\u0148a\u0165 ni\u017e\u0161ie uveden\u00e9 parametre:<\/strong><\/p>\n\n\n\n<ul><li>Hypoalerg\u00e9nna,<\/li><li>Povrch odoln\u00fd vo\u010di bakt\u00e9ri\u00e1m a&nbsp;hub\u00e1m.<\/li><\/ul>\n\n\n\n<p><strong>TECHNICK\u00c9 \u00daDAJE<\/strong><\/p>\n\n\n\n<ul><li>Zdroj energie: max. 3ks 1,5 V AA LR6 alkalick\u00fdch bat\u00e9ri\u00ed,<\/li><li>Doba prev\u00e1dzky: min. 90 min\u00fat nepretr\u017eit\u00e9ho pou\u017e\u00edvania,<\/li><li>Sie\u0165ov\u00e1 prev\u00e1dzka s volite\u013en\u00fdm adapt\u00e9rom,<\/li><li>Teplota: v min. rozsahu -25 \u00b0C &#8211; +70 \u00b0C,<\/li><li>Vlhkos\u0165: &lt; 93 % bez kondenz\u00e1cie,<\/li><li>Frekvencia ultrazvuku: minim\u00e1lne 100 kHz,<\/li><li>Striekanie: min. 0,25 ml\/min,<\/li><li>Percento aeros\u00f3lu: min. 50 % \u010dast\u00edc \u2013 menej ako 5 \u03bcm,<\/li><li>Priemern\u00e1 ve\u013ekos\u0165 \u010dast\u00edc: max. 4,8 \u03bcm,<\/li><li>Mno\u017estvo inhala\u010dn\u00e9ho pr\u00edpravku: min. 9 ml &#8211; max. 10 ml,&nbsp;<\/li><li>Rozmery: min. 12 x 5 x 5 cm \u2013 max. 13 x 6 x 6 cm,<\/li><li>Hmotnos\u0165: max. 160 g (bez bat\u00e9rie).<\/li><\/ul>\n\n\n\n<p><strong>PREV\u00c1DZKOV\u00c9 PODMIENKY<\/strong><\/p>\n\n\n\n<ul><li>Teplota: v min. rozsahu +5 \u00b0C &#8211; +40 \u00b0C,<\/li><li>Vlhkos\u0165 vzduchu: v&nbsp;min. rozsahu 15 % &#8211; 93 %.<\/li><\/ul>\n\n\n\n<p><strong>V\u00fdsledkom Zmluvy o&nbsp;dielo je povinnos\u0165 Zhotovite\u013ea vyvin\u00fa\u0165 terapeutick\u00fa masku v&nbsp;s\u00falade s&nbsp;vy\u0161\u0161ie uv\u00e1dzanou \u0161pecifik\u00e1ciou a&nbsp;doda\u0165 Objedn\u00e1vate\u013eovi jeden prototyp.<\/strong><\/p>\n\n\n\n<p>Zad\u00e1vate\u013e stanovil minim\u00e1lne po\u017eiadavky, ktor\u00e9 po\u017eaduje dodr\u017ea\u0165 pre dan\u00fd predmet z\u00e1kazky. V pr\u00edpade, \u017ee zad\u00e1vate\u013e v r\u00e1mci opisu predmetu z\u00e1kazky uviedol konkr\u00e9tneho v\u00fdrobcu, v\u00fdrobn\u00fd postup, zna\u010dku, patent, typ, krajinu, oblas\u0165 alebo miesto p\u00f4vodu alebo v\u00fdroby, m\u00f4\u017ee uch\u00e1dza\u010d predlo\u017ei\u0165 ponuku i na technick\u00fd a funk\u010dn\u00fd ekvivalent. V pr\u00edpade odkazu na normy alebo predpisy zad\u00e1vate\u013e z\u00e1kazky akceptuje aj ich ekvivalent.<\/p>\n\n\n\n<ol start=\"7\"><li>7, <strong>Miesto a term\u00edn dodania predmetu z\u00e1kazky:&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<p><strong>Miesto dodania: <\/strong>Herb-Pharma Corporation s.r.o., Ve\u013ek\u00e9 Ludince 654, 935 65 Ve\u013ek\u00e9 Ludince<\/p>\n\n\n\n<p><strong>Term\u00edn dodania predmetu z\u00e1kazky:<\/strong> maxim\u00e1lne&nbsp; 4 mesiace od \u00fa\u010dinnosti Zmluvy o dielo.<\/p>\n\n\n\n<ol start=\"8\"><li>8, <strong>Lehoty na dodanie alebo dokon\u010denie predmetu z\u00e1kazky alebo trvanie zmluvy: <\/strong>ako je uveden\u00e9 v&nbsp;bode 7.&nbsp;<\/li><li>9, <strong>S\u00fa\u0165a\u017en\u00e9 podklady k v\u00fdzve na predlo\u017eenie cenovej ponuky: <\/strong>s\u00fa s\u00fa\u010das\u0165ou v\u00fdzvy.<\/li><li>10, <strong>Financovanie predmetu z\u00e1kazky: <\/strong>z\u00e1kazka bude spolufinancovan\u00e1 z&nbsp;prostriedkov Eur\u00f3pskej \u00danie poskytnut\u00fdch v&nbsp;r\u00e1mci opera\u010dn\u00e9ho programu Integrovan\u00e1 infra\u0161trukt\u00fara, konkr\u00e9tne v&nbsp;s\u00falade s <strong>v\u00fdzvou<\/strong>zameranou na podporu \u00fa\u010dasti slovensk\u00fdch v\u00fdskumn\u00fdch in\u0161tit\u00faci\u00ed v medzin\u00e1rodn\u00fdch v\u00fdskumn\u00fdch projektoch zameran\u00fdch na boj proti pand\u00e9mii vyvolanej ochoren\u00edm COVID-19&nbsp; (OPII-VA\/DP\/2020\/9.2-01 ).<\/li><li>11, <strong>Lehota na predlo\u017eenie ponuky: <\/strong>do <strong>03.08.2022&nbsp;<\/strong><\/li><li>12, <strong>Sp\u00f4sob predlo\u017eenia ponuky: <\/strong>Ponuky je potrebn\u00e9 doru\u010di\u0165 osobne alebo po\u0161tou v lehote na predkladanie pon\u00fak v uzavretom, neprieh\u013eadnom obale s uveden\u00edm obchodn\u00e9ho mena a s\u00eddla alebo miesta podnikania uch\u00e1dza\u010da. Obal mus\u00ed by\u0165 ozna\u010den\u00fd textom: <strong>Cenov\u00e1 ponuka &#8211; \u201eV\u00fdvoj terapeutickej masky\u201c &#8211; Neotv\u00e1ra\u0165<\/strong>, alebo elektronicky na e-mailov\u00fa adresu:&nbsp;<\/li><\/ol>\n\n\n\n<ul><li><a href=\"mailto:marko.stanko@eufc.sk\">marko.stanko@eufc.sk<\/a><\/li><\/ul>\n\n\n\n<p>V pr\u00edpade doru\u010denia po\u0161tou mus\u00ed by\u0165 ponuka v stanovenej lehote doru\u010den\u00e1 na adresu:&nbsp; &nbsp;<\/p>\n\n\n\n<p><strong><em>Herb-Pharma Corporation, Ve\u013ek\u00e9 Ludince 654, 935 65 Ve\u013ek\u00e9 Ludince<\/em><\/strong><\/p>\n\n\n\n<p><strong>UPOZORNENIE:<em> D\u00e1tum po\u0161tovej pe\u010diatky nie je rozhoduj\u00faci.&nbsp;<\/em><\/strong><\/p>\n\n\n\n<p><strong>V pr\u00edpade zaslania ponuky formou e-mailu posta\u010duje sken origin\u00e1lnych dokumentov vr\u00e1tane podpisu a pe\u010diatky uch\u00e1dza\u010da vo form\u00e1te PDF, pr\u00edpadne vo form\u00e1te JPG.<\/strong><\/p>\n\n\n\n<ol start=\"13\"><li>13, <strong>Krit\u00e9ri\u00e1 na vyhodnotenie pon\u00fak s pravidlami ich uplatnenia a sp\u00f4sob hodnotenia pon\u00fak:&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<p>Jedin\u00fdm krit\u00e9riom je najni\u017e\u0161ie <strong>CENA v EUR bez DPH za cel\u00fd predmet z\u00e1kazky&nbsp;<\/strong><\/p>\n\n\n\n<ol start=\"14\"><li><strong>14, Podmienky \u00fa\u010dasti a dokumenty po\u017eadovan\u00e9 zad\u00e1vate\u013eom:<\/strong><\/li><\/ol>\n\n\n\n<p>Uch\u00e1dza\u010d mus\u00ed sp\u013a\u0148a\u0165 podmienky \u00fa\u010dasti t\u00fdkaj\u00face sa osobn\u00e9ho postavenia pod\u013ea \u00a7 32 ods.1 p\u00edsm. e) a f) z\u00e1kona \u010d. 343\/2015 Z. z. o verejnom obstar\u00e1van\u00ed (\u010falej len \u201cZVO\u201d) t. j. mus\u00ed by\u0165 opr\u00e1vnen\u00fd dod\u00e1va\u0165 tovar, uskuto\u010d\u0148ova\u0165 stavebn\u00e9 pr\u00e1ce alebo poskytova\u0165 slu\u017ebu, ktor\u00e1 zodpoved\u00e1 predmetu z\u00e1kazky a nem\u00e1 ulo\u017een\u00fd z\u00e1kaz \u00fa\u010dasti vo verejnom obstar\u00e1van\u00ed potvrden\u00fd kone\u010dn\u00fdm rozhodnut\u00edm v Slovenskej republike alebo v \u0161t\u00e1te s\u00eddla, miesta podnikania alebo obvykl\u00e9ho pobytu.&nbsp;<\/p>\n\n\n\n<p>Uch\u00e1dza\u010d predlo\u017e\u00ed doklad pod\u013ea \u00a7 32 ods. 1, p\u00edsm. f) ZVO vo forme \u010cestn\u00e9ho vyhl\u00e1senia, ktor\u00e9 je s\u00fa\u010dastou Pr\u00edlohy \u010d. 3 tejto v\u00fdzvy.&nbsp;<\/p>\n\n\n\n<p>Uch\u00e1dza\u010d nie je povinn\u00fd predklada\u0165 doklady pod\u013ea \u00a7 32, ods. 2, p\u00edsm. e) ZVO. Zad\u00e1vate\u013e je opr\u00e1vnen\u00fd pou\u017ei\u0165 \u00fadaje z informa\u010dn\u00fdch syst\u00e9mov verejnej spr\u00e1vy.<\/p>\n\n\n\n<p>Ak ponuku predklad\u00e1 uch\u00e1dza\u010d so s\u00eddlom mimo \u00fazemia Slovenskej republiky, mus\u00ed predlo\u017ei\u0165 doklady, ktor\u00fdmi preukazuje splnenie podmienok \u00fa\u010dasti vo verejnom obstar\u00e1van\u00ed v p\u00f4vodnom jazyku a s\u00fa\u010dasne predlo\u017ei\u0165 \u00faradn\u00fd preklad tak\u00fdchto dokladov do \u0161t\u00e1tneho jazyka, okrem dokladov predlo\u017een\u00fdch v \u010deskom jazyku. Ak sa zist\u00ed rozdiel v ich obsahu, rozhoduj\u00faci je \u00faradn\u00fd preklad v slovenskom jazyku, okrem dokladov predlo\u017een\u00fdch v \u010deskom jazyku<\/p>\n\n\n\n<ol start=\"15\"><li>15, <strong>Pokyny na zostavenie ponuky:&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<ul><li>Uch\u00e1dza\u010d m\u00f4\u017ee predlo\u017ei\u0165 len jednu ponuku.<\/li><li><strong>Jazyk vyhotovenia ponuky: <\/strong>Ponuka potenci\u00e1lneho dod\u00e1vate\u013ea mus\u00ed by\u0165 predlo\u017een\u00e1 v slovenskom alebo \u010deskom jazyku.&nbsp;<\/li><li><strong>Variantn\u00e9 rie\u0161enie:<\/strong> neumo\u017e\u0148uje sa<\/li><\/ul>\n\n\n\n<p><strong>Po\u017eadujeme, aby ponuka obsahovala nasledovn\u00e9 doklady a \u00fadaje<\/strong>:&nbsp;<\/p>\n\n\n\n<ol><li>a) <strong>Vyplnen\u00e1 a&nbsp;podp\u00edsan\u00e1 <em>pr\u00edloha \u010d. 1 <\/em><\/strong><em>\u2013<\/em> <strong><em>Kryc\u00ed list ponuky<\/em><\/strong><\/li><\/ol>\n\n\n\n<ul><li>naskenovan\u00fd dokument v&nbsp;pr\u00edpade elektronicky predlo\u017een\u00e9ho dokladu<\/li><\/ul>\n\n\n\n<ol start=\"2\"><li>b) <strong>Vyplnen\u00e1 a&nbsp;podp\u00edsan\u00e1 <em>pr\u00edloha \u010d.2 <\/em><\/strong><em>\u2013<\/em> <strong><em>Vecn\u00e1 a&nbsp;cenov\u00e1 \u0161pecifik\u00e1cia diela&nbsp;<\/em><\/strong><\/li><\/ol>\n\n\n\n<ul><li>naskenovan\u00fd dokument v&nbsp;pr\u00edpade elektronicky predlo\u017een\u00e9ho dokladu<\/li><\/ul>\n\n\n\n<ol start=\"3\"><li>c) <strong>Vyplnen\u00e1 a&nbsp;podp\u00edsan\u00e1 <em>pr\u00edloha \u010d.3 <\/em><\/strong><em>\u2013<\/em> <strong><em>\u010cestn\u00e9 vyhl\u00e1senie<\/em><\/strong><\/li><\/ol>\n\n\n\n<ul><li>naskenovan\u00fd dokument v&nbsp;pr\u00edpade elektronicky predlo\u017een\u00e9ho dokladu<\/li><\/ul>\n\n\n\n<ol start=\"4\"><li>d) <strong>Vyplnen\u00e1 a&nbsp;podp\u00edsan\u00e1 <em>pr\u00edloha \u010d.4 <\/em><\/strong><em>\u2013<\/em> <strong><em>Zmluva o&nbsp;dielo vr\u00e1tane \u010cestn\u00e9 vyhl\u00e1senie o subdod\u00e1vate\u013eoch<\/em><\/strong><\/li><\/ol>\n\n\n\n<ul><li>naskenovan\u00fd dokument v&nbsp;pr\u00edpade elektronicky predlo\u017een\u00e9ho dokladu<\/li><\/ul>\n\n\n\n<ol start=\"16\"><li>16, <strong>Mena a ceny uv\u00e1dzan\u00e9 v&nbsp;ponuke:<\/strong><\/li><\/ol>\n\n\n\n<p>Cena mus\u00ed by\u0165 stanoven\u00e1 pod\u013ea \u00a7 3 z\u00e1kona NR SR \u010d.18\/1996 Z. z. o cen\u00e1ch v znen\u00ed neskor\u0161\u00edch predpisov a vyhl\u00e1\u0161ky MF SR \u010d. 87\/1996 Z. z., ktorou sa vykon\u00e1va z\u00e1kon \u010d. NR SR \u010d.18\/1996 Z. z. o cen\u00e1ch v znen\u00ed neskor\u0161\u00edch predpisov.<\/p>\n\n\n\n<p>Uch\u00e1dza\u010dom navrhovan\u00e1 cena bude vyjadren\u00e1 v Eur\u00e1ch. Cenov\u00e1 ponuka v inej mene ako EURO mus\u00ed by\u0165 prepo\u010d\u00edtan\u00e1 na EURO. V\u00fd\u0161ku ceny ponuky uch\u00e1dza\u010d prepo\u010d\u00edta kurzom N\u00e1rodnej banky Slovenska (\u010falej len \u201eNBS\u201c) platn\u00fdm v de\u0148 vypracovania cenovej ponuky a prepo\u010det potvrd\u00ed svojim podpisom.<\/p>\n\n\n\n<p>Ak je uch\u00e1dza\u010d platcom dane z pridanej hodnoty (\u010falej len \u201eDPH\u201c), cenu uvedie v zlo\u017een\u00ed:&nbsp;<\/p>\n\n\n\n<p>Cena za predmet z\u00e1kazky v Eur (bez DPH) v\u00fd\u0161ka DPH v Eur celkov\u00e1 cena v Eur (s DPH)<\/p>\n\n\n\n<p>Ak uch\u00e1dza\u010d nie je platcom DPH, uvedie celkov\u00fa cenu. Na skuto\u010dnos\u0165, \u017ee nie je platite\u013eom DPH, upozorn\u00ed\/uvedie v ponuke.<\/p>\n\n\n\n<ol start=\"17\"><li>17, <strong>Otv\u00e1ranie pon\u00fak: <\/strong>Herb-Pharma Corporation s.r.o., Ve\u013ek\u00e9 Ludince 654, 935 65 Ve\u013ek\u00e9 Ludince, d\u0148a <strong>04.08.2022 o&nbsp;09:00h<\/strong><\/li><li>18, <strong>Postup pri otv\u00e1ran\u00ed pon\u00fak: <\/strong>Otv\u00e1ranie pon\u00fak je neverejn\u00e9.&nbsp;<\/li><li>19, <strong>Lehota viazanosti pon\u00fak<\/strong>: do <strong>30.11.2022<\/strong>&nbsp;<\/li><li>20, <strong>Osoby ur\u010den\u00e9 pre styk so z\u00e1ujemcami a uch\u00e1dza\u010dmi:&nbsp;<\/strong><\/li><\/ol>\n\n\n\n<p>Ing. Silvia Berekov\u00e1, mana\u017e\u00e9r VO &#8211; <a href=\"mailto:quality2@herb-pharma.\">quality2@herb-pharma.<\/a>com<\/p>\n\n\n\n<p>Mgr. Marko Stanko, administr\u00e1tor VO &#8211; <a href=\"mailto:marko.stanko@eufc.sk\">marko.stanko@eufc.sk<\/a><\/p>\n\n\n\n<ol start=\"21\"><li>21, <strong>\u010eal\u0161ie inform\u00e1cie zad\u00e1vate\u013ea:<\/strong><\/li><\/ol>\n\n\n\n<ul><li>Ak bola predlo\u017een\u00e1 viac ako jedna ponuka, zad\u00e1vate\u013e vyhodnocuje splnenie po\u017eiadaviek na predmet z\u00e1kazky a splnenie podmienok \u00fa\u010dasti (ak relevantn\u00e9) po vyhodnoten\u00ed pon\u00fak na z\u00e1klade krit\u00e9ri\u00e1\/krit\u00e9ri\u00ed na vyhodnotenie pon\u00fak, a to iba v pr\u00edpade dod\u00e1vate\u013ea, ktor\u00fd sa umiestnil na prvom mieste v porad\u00ed. Uveden\u00e9 pravidl\u00e1 nevylu\u010duj\u00fa, aby zad\u00e1vate\u013e vyhodnotil splnenie po\u017eiadaviek na predmet z\u00e1kazky a splnenie podmienok \u00fa\u010dasti v pr\u00edpade v\u0161etk\u00fdch dod\u00e1vate\u013eov, ktor\u00ed predlo\u017eili ponuku. Zad\u00e1vate\u013e je povinn\u00fd uzatvori\u0165 zmluvu\/zada\u0165 objedn\u00e1vku v s\u00falade s v\u00fdzvou na predkladanie pon\u00fak a s ponukou \u00faspe\u0161n\u00e9ho dod\u00e1vate\u013ea.&nbsp;<\/li><li>Subdod\u00e1vate\u013e mus\u00ed sp\u013a\u0148a\u0165 podmienky \u00fa\u010dasti v zmysle bodu 14. tejto v\u00fdzvy vo vz\u0165ahu k tej \u010dasti predmetu z\u00e1kazky, ktor\u00fa m\u00e1 tento subdod\u00e1vate\u013e plni\u0165.<\/li><li>Zad\u00e1vate\u013e neuzavrie zmluvu s uch\u00e1dza\u010dom, ktor\u00fd m\u00e1 povinnos\u0165 zap\u00edsania do registra partnerov verejn\u00e9ho sektora a nie je zap\u00edsan\u00fd v registri partnerov verejn\u00e9ho sektora alebo ktor\u00fdch subdod\u00e1vatelia, ktor\u00ed maj\u00fa povinnos\u0165 zapisova\u0165 sa do registra partnerov verejn\u00e9ho sektora a nie s\u00fa zap\u00edsan\u00ed v registri partnerov verejn\u00e9ho sektora.<\/li><li>Zad\u00e1vate\u013e m\u00f4\u017ee zru\u0161i\u0165 pou\u017eit\u00fd postup zad\u00e1vania z\u00e1kazky, ak&nbsp;<\/li><\/ul>\n\n\n\n<ol><li>ani jeden potenci\u00e1lny dod\u00e1vate\u013e nesplnil podmienky uveden\u00e9 vo v\u00fdzve na predkladanie pon\u00fak,&nbsp;<\/li><li>ak sa zmenili okolnosti, za ktor\u00fdch sa vyhl\u00e1silo obstar\u00e1vanie&nbsp;<\/li><\/ol>\n\n\n\n<ul><li>Zad\u00e1vate\u013e si vyhradzuje pr\u00e1vo neprija\u0165 ani jednu ponuku z predlo\u017een\u00fdch pon\u00fak v pr\u00edpade, \u017ee predlo\u017een\u00e9 ponuky nebud\u00fa v\u00fdhodn\u00e9 pre zad\u00e1vate\u013ea alebo bud\u00fa v rozpore s finan\u010dn\u00fdmi mo\u017enos\u0165ami zad\u00e1vate\u013ea.<\/li><li>Ponuky uch\u00e1dza\u010dov musia by\u0165 vypracovan\u00e9 v rozsahu a forme pod\u013ea po\u017eiadaviek zad\u00e1vate\u013ea stanoven\u00fdch v tejto v\u00fdzve a jej pr\u00edloh\u00e1ch.<\/li><li>V pr\u00edpade osobn\u00e9ho doru\u010denia ponuky zo strany potenci\u00e1lneho dod\u00e1vate\u013ea, je povinnos\u0165ou zad\u00e1vate\u013ea vyda\u0165 uch\u00e1dza\u010dovi potvrdenie o prevzat\u00ed ponuky, ak o to potenci\u00e1lny dod\u00e1vate\u013e po\u017eiada.<\/li><li>V\u0161etky n\u00e1klady a v\u00fddavky spojen\u00e9 s pr\u00edpravou a predlo\u017een\u00edm ponuky zn\u00e1\u0161a uch\u00e1dza\u010d bez finan\u010dn\u00e9ho n\u00e1roku vo\u010di zad\u00e1vate\u013eovi, bez oh\u013eadu na v\u00fdsledok obstar\u00e1vania.<\/li><li>Predlo\u017een\u00e1 cenov\u00e1 ponuka mus\u00ed obsahova\u0165 v\u0161etky n\u00e1klady spojen\u00e9 s realiz\u00e1ciou predmetu z\u00e1kazky.&nbsp;<\/li><li>Platnou ponukou je ponuka, ktor\u00e1 neobsahuje \u017eiadne v\u00fdhrady vo\u010di po\u017eiadavk\u00e1m, pokynom a \u0161pecifik\u00e1ci\u00e1m uveden\u00fdm v tejto v\u00fdzve a z\u00e1rove\u0148 neobsahuje \u017eiadne obmedzenia alebo v\u00fdhrady, ktor\u00e9 by boli v rozpore s \u0148ou alebo ktor\u00e1 by bola inak neprijate\u013en\u00e1<\/li><li>V\u00ed\u0165azn\u00fd uch\u00e1dza\u010d\/Zhotovite\u013e sa zav\u00e4zuje strpie\u0165 v\u00fdkon kontroly\/auditu, overovania s\u00favisiaceho s dod\u00e1van\u00fdm tovarom, slu\u017ebami a stavebn\u00fdmi pr\u00e1cami t. j. s&nbsp;dodan\u00edm predmetu zmluvy kedyko\u013evek po\u010das platnosti a \u00fa\u010dinnosti Zmluvy o poskytnut\u00ed nen\u00e1vratn\u00e9ho finan\u010dn\u00e9ho pr\u00edspevku, ktor\u00fa m\u00e1 nadob\u00fadate\u013e uzavret\u00fa s poskytovate\u013eom nen\u00e1vratn\u00e9ho finan\u010dn\u00e9ho pr\u00edspevku t. j. do uplynutia leh\u00f4t pod\u013ea \u010dl\u00e1nku 7 odsek 7.2 zmluvy o&nbsp;poskytnut\u00ed NFP a to opr\u00e1vnen\u00fdmi osobami na v\u00fdkon tejto kontroly\/auditu\/overovania a&nbsp;poskytn\u00fa\u0165 im v\u0161etku potrebn\u00fa s\u00fa\u010dinnos\u0165.<\/li><\/ul>\n\n\n\n<p><strong>Opr\u00e1vnen\u00fdmi osobami na v\u00fdkon kontroly\/auditu s\u00fa najm\u00e4:<\/strong><\/p>\n\n\n\n<ol><li>a)Poskytovate\u013e a n\u00edm poveren\u00e9 osoby,&nbsp;<\/li><\/ol>\n\n\n\n<ol start=\"2\"><li>b) \u00datvar vn\u00fatorn\u00e9ho auditu Riadiaceho org\u00e1nu alebo Sprostredkovate\u013esk\u00e9ho org\u00e1nu a nimi&nbsp; poveren\u00e9 osoby,&nbsp;<\/li><li>c) Najvy\u0161\u0161\u00ed kontroln\u00fd \u00farad SR a n\u00edm poveren\u00e9 osoby,<\/li><li>d) Org\u00e1n auditu, jeho spolupracuj\u00face org\u00e1ny (\u00darad vl\u00e1dneho auditu) a osoby poveren\u00e9 na v\u00fdkon kontroly\/auditu,&nbsp;<\/li><li>e )Splnomocnen\u00ed z\u00e1stupcovia Eur\u00f3pskej Komisie a Eur\u00f3pskeho dvora aud\u00edtorov,<\/li><li>f) Org\u00e1n zabezpe\u010duj\u00faci ochranu finan\u010dn\u00fdch z\u00e1ujmov E\u00da,<\/li><li>g) Osoby prizvan\u00e9 org\u00e1nmi uveden\u00fdmi v p\u00edsm. a) a\u017e f) v s\u00falade s pr\u00edslu\u0161n\u00fdmi Pr\u00e1vnymi predpismi SR a pr\u00e1vnymi aktmi E\u00da<\/li><\/ol>\n\n\n\n<ul><li>Zad\u00e1vate\u013e v lehote do 5 pracovn\u00fdch dn\u00ed od vyhodnotenia pon\u00fak ozn\u00e1mi v\u0161etk\u00fdm uch\u00e1dza\u010dom v\u00fdsledok ich vyhodnotenia. \u00daspe\u0161n\u00e9mu uch\u00e1dza\u010dovi ozn\u00e1mi, \u017ee jeho ponuku prij\u00edma, ostatn\u00fdm uch\u00e1dza\u010dom ozn\u00e1mi, \u017ee s\u00fa ne\u00faspe\u0161n\u00ed.<\/li><\/ul>\n\n\n\n<ol start=\"22\"><li>22, <strong>Z\u00e1kazka sa t\u00fdka projektu \/ programu financovan\u00e9ho z&nbsp;fondov E\u00da:<\/strong><\/li><\/ol>\n\n\n\n<p>K\u00f3d projektu: <strong><em>313011AUZ6<\/em><\/strong><\/p>\n\n\n\n<p>N\u00e1zov projektu: <strong><em>Podpora v\u00fdskumu pri boki proti pand\u00e9mii vyvolanej ochoren\u00edm COVID-19<\/em><\/strong><\/p>\n\n\n\n<p>V\u00fdzva: <strong><em>OPII-VA\/DP\/2020\/9.2-01 &#8211; V\u00fdzva na predkladanie \u017eiadost\u00ed o poskytnutie nen\u00e1vratn\u00e9ho finan\u010dn\u00e9ho pr\u00edspevku na podporu \u00fa\u010dasti slovensk\u00fdch v\u00fdskumn\u00fdch in\u0161tit\u00faci\u00ed v medzin\u00e1rodn\u00fdch v\u00fdskumn\u00fdch projektoch zameran\u00fdch na boj proti pand\u00e9mii vyvolanej ochoren\u00edm COVID-19<\/em><\/strong><\/p>\n\n\n\n<p>Opera\u010dn\u00fd program: <strong><em>Integrovan\u00e1 infra\u0161trukt\u00fara<\/em><\/strong><\/p>\n\n\n\n<p>Prioritn\u00e1 os: <strong><em>9 Podpora v\u00fdskumu, v\u00fdvoja a inov\u00e1ci\u00ed&nbsp;<\/em><\/strong><\/p>\n\n\n\n<p>\u0160pecifick\u00fd cie\u013e: <strong><em>9.2 Zv\u00fd\u0161enie \u00fa\u010dasti SR v projektoch medzin\u00e1rodnej spolupr\u00e1ce<\/em><\/strong>&nbsp;<\/p>\n\n\n\n<ol start=\"23\"><li>23, <strong>D\u00e1tum zaslania v\u00fdzvy na predkladanie pon\u00fak:<\/strong><\/li><\/ol>\n\n\n\n<p>&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.&nbsp;<\/p>\n\n\n\n<p><em>&nbsp; Ing. Ondrej Michlo<\/em><\/p>\n\n\n\n<p><em>konate\u013e spolo\u010dnosti<\/em><\/p>\n\n\n\n<p><strong>Pr\u00edlohy:&nbsp;<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/07\/Priloha-c.-1.docx\">Pr\u00edloha \u010d. 1 \u2013 Kryc\u00ed list ponuky<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/07\/Priloha-c.-2.docx\">Pr\u00edloha \u010d. 2 \u2013 Vecn\u00e1 a cenov\u00e1 \u0161pecifik\u00e1cia Diela<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/07\/Priloha-c.-3.docx\">Pr\u00edloha \u010d. 3 \u2013 \u010cestn\u00e9 vyhl\u00e1senie<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/07\/Priloha-c.-4.docx\">Pr\u00edloha \u010d. 4 \u2013&nbsp; Zmluva o dielo vr\u00e1tane pr\u00edlohy \u010cestn\u00e9 vyhl\u00e1senie o subdod\u00e1vate\u013eoch &#8211; n\u00e1vrh &nbsp;<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/08\/Zaznam-z-prieskumu-trhu-maska-na-zverejnenie-2.pdf\">Z\u00e1znam z prieskum trhu<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>z\u00e1kazka zad\u00e1van\u00e1 osobou, ktorej poskytne SO viac ako 50 %&nbsp; alebo 50 % a menej finan\u010dn\u00fdch prostriedkov z&nbsp;NFP&nbsp; (\u010falej len \u201ezad\u00e1vate\u013e\u201c)&nbsp; Herb-Pharma Corporation s.r.o.; Ve\u013ek\u00e9 Ludince 654; 935 65 Ve\u013ek\u00e9 Ludince V\u00fdzva na predkladanie pon\u00fak v&nbsp;r\u00e1mci realiz\u00e1cie procesu zad\u00e1vania z\u00e1kazky pod\u013ea aktu\u00e1lne platnej Jednotnej pr\u00edru\u010dky pre \u017eiadate\u013eov\/prij\u00edmate\u013eov k&nbsp;procesu a kontrole verejn\u00e9ho obstar\u00e1vania\/obstar\u00e1vanie, verzia 2, vydan\u00e1 &hellip; <a href=\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\">Continued<\/a><\/p>\n","protected":false},"author":2,"featured_media":2268,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[40],"tags":[],"yoast_head":"<title>V\u00fdzva na predkladanie pon\u00fak - Fytofontana<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"V\u00fdzva na predkladanie pon\u00fak - Fytofontana\" \/>\n<meta property=\"og:description\" content=\"z\u00e1kazka zad\u00e1van\u00e1 osobou, ktorej poskytne SO viac ako 50 %&nbsp; alebo 50 % a menej finan\u010dn\u00fdch prostriedkov z&nbsp;NFP&nbsp; (\u010falej len \u201ezad\u00e1vate\u013e\u201c)&nbsp; Herb-Pharma Corporation s.r.o.; Ve\u013ek\u00e9 Ludince 654; 935 65 Ve\u013ek\u00e9 Ludince V\u00fdzva na predkladanie pon\u00fak v&nbsp;r\u00e1mci realiz\u00e1cie procesu zad\u00e1vania z\u00e1kazky pod\u013ea aktu\u00e1lne platnej Jednotnej pr\u00edru\u010dky pre \u017eiadate\u013eov\/prij\u00edmate\u013eov k&nbsp;procesu a kontrole verejn\u00e9ho obstar\u00e1vania\/obstar\u00e1vanie, verzia 2, vydan\u00e1 &hellip; Continued\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\" \/>\n<meta property=\"og:site_name\" content=\"Fytofontana\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-22T13:32:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-30T14:29:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/07\/Screenshot-2022-07-22-at-14.34.36.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1480\" \/>\n\t<meta property=\"og:image:height\" content=\"314\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\">\n\t<meta name=\"twitter:data1\" content=\"10 min\u00fat\">\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fytofontana.com\/#organization\",\"name\":\"Fytofontana\",\"url\":\"https:\/\/www.fytofontana.com\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fytofontana.com\/#logo\",\"inLanguage\":\"sk-SK\",\"url\":\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2021\/01\/fyto.png\",\"width\":817,\"height\":79,\"caption\":\"Fytofontana\"},\"image\":{\"@id\":\"https:\/\/www.fytofontana.com\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fytofontana.com\/#website\",\"url\":\"https:\/\/www.fytofontana.com\/\",\"name\":\"Fytofontana\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.fytofontana.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.fytofontana.com\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#primaryimage\",\"inLanguage\":\"sk-SK\",\"url\":\"https:\/\/www.fytofontana.com\/wp-content\/uploads\/2022\/07\/Screenshot-2022-07-22-at-14.34.36.png\",\"width\":1480,\"height\":314},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#webpage\",\"url\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\",\"name\":\"V\\u00fdzva na predkladanie pon\\u00fak - Fytofontana\",\"isPartOf\":{\"@id\":\"https:\/\/www.fytofontana.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#primaryimage\"},\"datePublished\":\"2022-07-22T13:32:18+00:00\",\"dateModified\":\"2022-08-30T14:29:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fytofontana.com\/sk\/\",\"url\":\"https:\/\/www.fytofontana.com\/sk\/\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\",\"url\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/\",\"name\":\"V\\u00fdzva na predkladanie pon\\u00fak\"}}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#webpage\"},\"author\":{\"@id\":\"https:\/\/www.fytofontana.com\/#\/schema\/person\/bc2dbece56d6d434ecc9683979969afe\"},\"headline\":\"V\\u00fdzva na predkladanie pon\\u00fak\",\"datePublished\":\"2022-07-22T13:32:18+00:00\",\"dateModified\":\"2022-08-30T14:29:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#webpage\"},\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fytofontana.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#primaryimage\"},\"articleSection\":\"Blog\",\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fytofontana.com\/sk\/blog\/vyvoj-terapeutickej-masky\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fytofontana.com\/#\/schema\/person\/bc2dbece56d6d434ecc9683979969afe\",\"name\":\"Anna Michlo\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fytofontana.com\/#personlogo\",\"inLanguage\":\"sk-SK\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/290886993260c0d0117cd8067acd8910?s=96&d=mm&r=g\",\"caption\":\"Anna Michlo\"}}]}<\/script>","_links":{"self":[{"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/posts\/2260"}],"collection":[{"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/comments?post=2260"}],"version-history":[{"count":21,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/posts\/2260\/revisions"}],"predecessor-version":[{"id":2349,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/posts\/2260\/revisions\/2349"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/media\/2268"}],"wp:attachment":[{"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/media?parent=2260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/categories?post=2260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fytofontana.com\/sk\/wp-json\/wp\/v2\/tags?post=2260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}